nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—FGF2—Differentiation Pathway—GDF5—degenerative disc disease	0.0689	0.0689	CbGpPWpGaD
Sirolimus—FKBP1A—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0625	0.0625	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—SOX9—degenerative disc disease	0.0522	0.0522	CbGpPWpGaD
Sirolimus—EIF4E—3' -UTR-mediated translational regulation—RPL34—degenerative disc disease	0.0454	0.0454	CbGpPWpGaD
Sirolimus—EIF4E—GTP hydrolysis and joining of the 60S ribosomal subunit—RPL34—degenerative disc disease	0.045	0.045	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—ADAMTS5—degenerative disc disease	0.0437	0.0437	CbGpPWpGaD
Sirolimus—EIF4E—Cap-dependent Translation Initiation—RPL34—degenerative disc disease	0.0428	0.0428	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—SOX9—degenerative disc disease	0.0422	0.0422	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—ADAMTS4—degenerative disc disease	0.0372	0.0372	CbGpPWpGaD
Sirolimus—FGF2—Neural Crest Differentiation—SOX9—degenerative disc disease	0.0362	0.0362	CbGpPWpGaD
Sirolimus—EIF4E—Translation—RPL34—degenerative disc disease	0.0348	0.0348	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of mRNA—RPL34—degenerative disc disease	0.025	0.025	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—MMP13—degenerative disc disease	0.0235	0.0235	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of RNA—RPL34—degenerative disc disease	0.0214	0.0214	CbGpPWpGaD
Sirolimus—EIF4E—BDNF signaling pathway—BMP2—degenerative disc disease	0.0214	0.0214	CbGpPWpGaD
Sirolimus—FGF2—Signaling by PDGF—COL9A3—degenerative disc disease	0.019	0.019	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—GDF5—degenerative disc disease	0.0176	0.0176	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—MMP13—degenerative disc disease	0.0172	0.0172	CbGpPWpGaD
Sirolimus—CYP3A7—Metapathway biotransformation—CHST3—degenerative disc disease	0.0151	0.0151	CbGpPWpGaD
Sirolimus—FGF2—Signaling by PDGF—COL9A2—degenerative disc disease	0.0148	0.0148	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ADAMTS3—degenerative disc disease	0.0141	0.0141	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—COL9A3—degenerative disc disease	0.0141	0.0141	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ADAMTS5—degenerative disc disease	0.0141	0.0141	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—COL9A3—degenerative disc disease	0.0141	0.0141	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ADAMTS4—degenerative disc disease	0.012	0.012	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—ADAMTS3—degenerative disc disease	0.0118	0.0118	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—ADAMTS5—degenerative disc disease	0.0118	0.0118	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.0115	0.0115	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—BMP2—degenerative disc disease	0.0113	0.0113	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—COL9A2—degenerative disc disease	0.011	0.011	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—COL9A2—degenerative disc disease	0.011	0.011	CbGpPWpGaD
Sirolimus—CYP3A5—Metapathway biotransformation—CHST3—degenerative disc disease	0.0109	0.0109	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—RPL34—degenerative disc disease	0.0101	0.0101	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—ADAMTS4—degenerative disc disease	0.0101	0.0101	CbGpPWpGaD
Sirolimus—MTOR—BDNF signaling pathway—BMP2—degenerative disc disease	0.00881	0.00881	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—COL9A3—degenerative disc disease	0.00853	0.00853	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP13—degenerative disc disease	0.00757	0.00757	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—BMP2—degenerative disc disease	0.00731	0.00731	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CHST3—degenerative disc disease	0.00705	0.00705	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—RPL34—degenerative disc disease	0.00667	0.00667	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—COL9A2—degenerative disc disease	0.00666	0.00666	CbGpPWpGaD
Sirolimus—FGF2—Disease—CHST3—degenerative disc disease	0.00535	0.00535	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—COL9A3—degenerative disc disease	0.0051	0.0051	CbGpPWpGaD
Sirolimus—CYP3A4—Metapathway biotransformation—CHST3—degenerative disc disease	0.00508	0.00508	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP3—degenerative disc disease	0.00507	0.00507	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—PARK2—degenerative disc disease	0.00478	0.00478	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—RPL34—degenerative disc disease	0.00455	0.00455	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—PARK2—degenerative disc disease	0.00438	0.00438	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—COL9A2—degenerative disc disease	0.00398	0.00398	CbGpPWpGaD
Sirolimus—MTOR—Disease—CHST3—degenerative disc disease	0.00397	0.00397	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—COL9A3—degenerative disc disease	0.00374	0.00374	CbGpPWpGaD
Sirolimus—FGF2—Disease—RPL34—degenerative disc disease	0.00344	0.00344	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—PARK2—degenerative disc disease	0.00325	0.00325	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—COL9A2—degenerative disc disease	0.00292	0.00292	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CHST3—degenerative disc disease	0.00286	0.00286	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—COL9A3—degenerative disc disease	0.00284	0.00284	CbGpPWpGaD
Sirolimus—FGF2—Immune System—PARK2—degenerative disc disease	0.00266	0.00266	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—BMP2—degenerative disc disease	0.00265	0.00265	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CHST3—degenerative disc disease	0.00262	0.00262	CbGpPWpGaD
Sirolimus—MTOR—Disease—RPL34—degenerative disc disease	0.00256	0.00256	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—COL9A2—degenerative disc disease	0.00221	0.00221	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—COL9A3—degenerative disc disease	0.00211	0.00211	CbGpPWpGaD
Sirolimus—MTOR—Immune System—PARK2—degenerative disc disease	0.00197	0.00197	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—BMP2—degenerative disc disease	0.00194	0.00194	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CHST3—degenerative disc disease	0.0019	0.0019	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP3—degenerative disc disease	0.00184	0.00184	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—COL9A2—degenerative disc disease	0.00164	0.00164	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—BMP2—degenerative disc disease	0.00147	0.00147	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CHST3—degenerative disc disease	0.00143	0.00143	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP3—degenerative disc disease	0.00135	0.00135	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—BMP2—degenerative disc disease	0.00109	0.00109	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP3—degenerative disc disease	0.00102	0.00102	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CHST3—degenerative disc disease	0.000881	0.000881	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP3—degenerative disc disease	0.000758	0.000758	CbGpPWpGaD
